Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors: A case report
- 24 September 2021
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 69 (2) , e29368
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The genetic changes of Wilms tumourNature Reviews Nephrology, 2019
- Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534)Annals of Surgery, 2017
- Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and HepatoblastomaClinical Cancer Research, 2017
- A Case of Bilateral Cystic Partially Differentiated Nephroblastoma vs Cystic Wilms' Tumor: Highlighting a Diagnostic DilemmaUrology, 2016
- A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutationBritish Journal of Cancer, 2015
- Genotype–phenotype associations in WT1 glomerulopathyKidney International, 2014
- Risk Factors for End Stage Renal Disease in Non- WT1 -Syndromic Wilms TumorJournal of Urology, 2011
- Analysis of the Wilms' Tumor Suppressor Gene (WT1) in Patients 46,XY Disorders of Sex DevelopmentThe Journal of Clinical Endocrinology & Metabolism, 2011
- Current Issues in Wilms Tumor ManagementCurrent Problems in Cancer, 2005
- Constitutional and somatic mutations in the WTI gene in wilms' tumor patientsInternational Journal of Cancer, 1995